Stock data
Vir Biotechnology, Inc. (VIR)
Vir Biotechnology, Inc. (VIR) reported revenue of US$68.56M and net income of -US$437.99M for fiscal 2025. The figures below come from the company's SEC filings.
Annual results
Data as of 2025-12-31
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Diluted EPS |
|---|---|---|---|---|---|
| 2025 | US$68.56M | — | -US$479.33M | -US$437.99M | — |
| 2024 | US$74.20M | — | -US$587.16M | -US$521.96M | — |
| 2023 | US$86.18M | — | -US$684.30M | -US$615.06M | — |
| 2022 | US$1.62B | — | US$833.07M | US$515.84M | — |
| 2021 | US$1.10B | — | US$420.75M | US$528.58M | — |
Quarterly results
Data as of 2026-06-30
| Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| 2026-06-30 | US$238.95M | US$80.08M | — |
| 2026-03-31 | -US$0.03M | -US$125.69M | — |
| 2025-12-31 | US$64.07M | -US$42.92M | — |
| 2025-09-30 | US$0.24M | -US$163.14M | — |
| 2025-06-30 | US$1.21M | -US$110.96M | — |
| 2025-03-31 | US$3.03M | -US$120.97M | — |
| 2024-12-31 | US$12.37M | -US$104.59M | — |
| 2024-09-30 | US$2.38M | -US$213.72M | — |
Sources
- Source: SEC EDGAR company facts
Charts, drawing tools, and the P/E calculator are in the app, free to use.